Laboratory Research Collaboration
Laboratory research at Neurogenic has been divided into three, separate categories. The first is identifying the antigen which binds circulating schizophrenia-related auto-antibodies. The second is identifying the specific antigen peptide fragment (i.e. the epitope) which binds to the antibodies. The third is establishing an ELISA assay with epitope peptide derivatives which yields high sensitivity and specificity to exact antibodies present in the blood of schizophrenic patients as opposed to that of control group subjects.